To better serve our readers, we’re now publishing articles in real time. Our goal is to bring you reports and analysis as news happens. We’ll also use the digital format to bring you more and better content. As a subscriber, you’ll receive periodic e-mails alerting you of our latest headlines.
Our former monthly print edition of the newsletter is now an enhanced quarterly publication that is published in connection with national conferences. This all-color print edition is a compilation of our best previously published online stories.
Safety Net Hospitals for Pharmaceutical Access invites you to subscribe to the Drug Discount Monitor.
The Monitor is the definitive source for the latest news on the Public Health Service 340B drug discount program and related developments in the federal drug discount arena. The Monitor's Washington, D.C.-based staff has the inside scoop on 340B, a program that affects over 14,000 health care providers and over 800 pharmaceutical manufacturers. From new developments on the regulatory front to the latest news from Capitol Hill, you can count on the Monitor as your guide to the 340B program. The Monitor will also track the latest developments in drug pricing litigation impacting 340B and the Medicaid drug rebate programs.
Whether you are with a small 340B clinic, a large DSH hospital, the government, or the pharmaceutical industry, you cannot afford to miss out on the Monitor.
Who Should Subscribe?
Contact Tom Mirga for more information.
